目的 观察高通量血液透析(high-flux hemodialysis,HFHD)对维持性血液透析(maintenance hemodialysis,MHD)患者左心室结构和功能的影响,并探讨其可能的机制。方法 采用前瞻性、自身对照研究。88例常规MHD患者,转换为HFHD治疗24个月。于HFHD治疗前(0个月)、治疗12个月及治疗24个月后,采用超声心动图分别测定左心房、左心室的结构和功能,并抽取静脉血检测患者的临床指标。结果 转换为HFHD组患者在治疗12个月时,心功能指标LAD、LVPWT、IVST、LVEF、E/A与治疗前比较差异无统计学意义;LVDd、LVMI与治疗前比较,差异有统计学意义(P<0.05);在治疗24个月时,LAD、LVDd、LVPWT、LVEF与治疗前比较,差异有统计学意义(P<0.05)。经HFHD治疗24个月后,血清ALB、CH、TG、HDL、LDL、Scr、BUN、hs-CRP、DBP、MAP与治疗前比较无明显变化,Hb、Ca与治疗前比较明显升高 (P<0.05),而P、iPTH、β2-MG较治疗前明显降低(P<0.05)。结论 尿毒症患者普遍存在左心室肥厚。HFHD治疗虽然清除了PTH、β2-MG等中大分子毒素,改善了贫血,但并不能阻止MHD患者左心室舒张功能的进一步恶化。
Abstract
Objective To investigate the effects of high flux hemodialysis on cardiac structure and function in maintenance hemodialysis patients, and to study the possible mechanism. Methods The study was prospective and self-controlled.A totol of 88 patients on maintainance low flux hemodialysis were recruited, after changing to a high flux hemodialysis treatment for 24 months. Their cardiac structure and function were compared by echocardiography respectively. Serum creatinine(SCr), blood urea nitrogen(BUN), serum phosphorus(P), calcium(Ca), intact parathyroid hormone(iPTH), β2- microglobulin(β2-MG),high sensitivity C-reactive protein(hs-CRP), albumin(ALB),and hemoglobin(Hb) levels were determined after the switch for 0, 12 and 24 months. Results There was no significant atteration of the cardiac function indexes of LAD, LVPWT, IVST, LVEF, E/A, compared with before after 12 months’ treatment of HFHD.But patients with HDHF on treatment for 24 months, had significant alteration of the cardiac function indexes of LAD, LVDd, LVPWT, IVST, LVEF compared with before (P＜0.05). In patients with HDHF on the treatment for 24 months, the clinical indicators of serum ALB, CH, TG, HDL, LDL, Scr, BUN, hs-CRP, DBP, MAP had no differences before and after changing to HFHD, serum Hb and Ca significantly increased after changing to HFHD(P＜0.05),serum P, iPTH、β2-MG have significantly decreased after changing to HFHD(P＜0.05). Conclusions In MHD patients universally exists left ventricular hypertrophy. Although HFHD may remove plasma medium molecule and macromolecule toxins such as β2-MG, inflammation substance and improve uremia in the body, it can not improve left ventricular diastolic function.
关键词
高通量血液透析 /
左心室结构和功能 /
血磷 /
甲状旁腺激素 /
高敏C反应蛋白
Key words
high flux hemodialysis /
left ventricular structure and function /
serum phosphorus /
intact parathyroid hormone /
high sensitivity C-reactive protein
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Dhar S, Pressman G S, Subramanian S, et al. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence[J]. Postgrad Med J, 2009, 85(1004):299-302.
[2] US Renal Data System. Overall hospitalization and mortality[J]. Am J Kidney Dis, 2003, 42(6 Suppl 5):S1-1S230.
[3] Asci G, Tz H, Ozkahya M, et al. The impact of membrane permeability and dialysate purity on cardiovascular outcomes[J]. J Am Soc Nephrol, 2013,24(6):1014-1023.
[4] Boure T, Vanholder R. Biochemical and clinical evidence for uremic toxicity[J]. Artif Organs, 2004,28(3):248-253.
[5] Patel R K, Oliver S, Mark P B, et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging[J]. Clin J Am Soc Nephrol, 2009,4(9):1477-1483.
[6] Ok E, Asci G, Toz H, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study[J]. Nephrol Dial Transplant, 2013,28(1):192-202.
[7] Traut M, Haufe C C, Eismann U, et al. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations(Results of a cross-over study)[J]. Blood Purif, 2007,25(5-6):432-440.
[8] Duran M, Unal A, Inanc M T, et al. Hemodialysis does not impair ventricular functions over 2 years[J]. Hemodial Int, 2011,15(3):334-340.
[9] Zumrutdal A, Sezer S, Demircan S, et al. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis[J]. Nephrology (Carlton), 2005,10(5):453-458.
[10] Cheung A K, Rocco M V, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006,17(2):546-555.
[11] 刘 红,常 明,刘书馨, 等. 高通量透析对尿毒症患者心血管系统的影响及可能的机制探讨[J]. 大连医科大学学报, 2012,34(6):565-568.
[12] 徐丰博,孙 懿,刘惠兰. 高通量血液透析对维持性血液透析患者微炎症状态的影响[J]. 中国血液净化, 2011,10(3):133-135.
[13] 宋张红, 于为民. 高通量血液透析对终末期肾病患者炎症介质及心脏功能的影响[J]. 中国医药, 2013,8(z1):26-28.
PDF(690 KB)
